Iron deficiency is common in patients with chronic kidney disease (CKD) and administration of iron supplements could help maintain target levels of hemoglobin and reduce, or remove, the need for erythropoiesis-stimulating agents. In this Review, Besarab & Coyne discuss the efficacy, safety and practical recommendations for oral and intravenous therapy in the treatment of anemia in patients with CKD.
- Anatole Besarab
- Daniel W. Coyne